· February 8, 2010 3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil® for Hyperphosphatemia	(2010-02-09)
· January 26, 2010 3SBio Inc. To Report 2009 Fourth Quarter And Full Year Results on February 11, 2010	(2010-02-09)
· January 8, 2009 3SBio Inc. Applies For SFDA Registrational Trial For Feraheme™	(2010-01-08)
· November 12, 2009 3SBio Inc. Announces Unaudited Third Quarter 2009 Results	(2009-11-13)
· October 27, 2009 3SBio Inc. To Report 2009 Third Quarter Earnings On November 12, 2009	(2009-10-29)
· October 20, 2009 3SBio Inc. Announces Results of Annual General Meeting	(2009-10-20)
· Sept 6, 2009 3SBIO INC. TO HOLD 2009 ANNUAL GENERAL MEETING ON OCTOBER 12, 2009	(2009-09-09)
· August 11,2009 3SBIO Inc. Announces Unaudited Second Quarter 2009 Results	(2009-08-12)
· July 23, 2009 3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009	(2009-07-27)
· May 20, 2009 3SBio Inc. Announces Unaudited First Quarter 2009 Results	(2009-05-20)
· May 5, 2009 3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor	(2009-05-06)
· May 4, 2009 3SBio Inc. to Report 2009 First Quarter Earnings on May 19, 2009	(2009-05-06)
· March 11, 2009 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2008 Results	(2009-03-12)
· February 25, 2009 3SBio Inc. to Report 2008 Fourth Quarter and Full Year Earnings on March 11, 2009	(2009-03-08)
· March 5, 2009 3SBio Inc. Receives Official Recognition as a 'High-Tech Enterprise'	(2009-03-06)

Total 53 pieces，total 4 pages，Current page1 Top page Prev page Next page Last page Go to page